![]() |
市場調查報告書
商品編碼
1284232
2028 年泌尿外科器械市場預測——按產品類型、技術、應用、銷售渠道、最終用戶和地區分列的全球分析Urology Devices Market Forecasts to 2028 - Global Analysis By Product Type, Technology, Application, Sales Channel, End User and Geography |
根據 Stratistics MRC 的數據,2022 年全球泌尿外科器械市場規模將達到 403.1 億美元,預計到 2028 年將達到 575.1 億美元,預計複合年增長率為 6.1%。
稱為泌尿科設備的醫療設備用於識別各種泌尿科疾病。 一些泌尿系統問題,例如尿路感染 (UTI)、腎臟疾病、尿道癌、尿失禁和尿路結石,可以使用這些尖端程序進行治療。
根據歐洲泌尿外科協會的數據,高達 31% 的敗血症始於尿路結石,在美國和歐洲佔 280 萬至 980 萬例,死亡人數多達 160 萬。
導致 ESRD 的慢性腎功能衰竭是由未控制的糖尿病和未治療的高血壓引起的。 此外,腎結石在世界範圍內變得越來越普遍。 腎結石病在西方國家多發。 在西方國家,男性腎結石的終生患病率為8%至12%,女性為5%至7%。 肥胖是腎結石最常見的危險因素。 在經合組織國家,大約六分之一的兒童和超過二分之一的成年人超重或肥胖。 因此,預計在預測期內腎結石病會增加。
由於感染、出血、尿瀦留和膀胱穿孔等許多副作用,膀胱鏡檢查的市場採用率急劇下降。 根據 MMR,到 2020 年,與辦公室膀胱鏡檢查相關的 UTI 感染將增加 10-20%。 這些副作用預計會在一定程度上限制膀胱鏡的使用。 此外,泌尿外科設備的高成本阻礙了市場的擴張。 許多政府和組織已就與使用這些設備相關的缺點對泌尿外科醫院進行了指導。 與此類泌尿外科設備相關的感染預計會阻礙市場擴張。
治療 BPH 的主要困難之一是處理性問題。 射精障礙和 ED 與 BPH 的常規 TURP 治療有關。 因此,如果您擔心維持性功能,我們建議您選擇 Urolift。 正在研究銩光纖激光器 (TFL) 作為鈥激光的替代品用於腎結石治療的碎石術。 對於碎石術,TFL 與鈥激光相比具有許多潛在優勢,包括消融閾值低 4 倍、近乎單模光束輪廓和更高的脈衝率。
與靜脈血栓形成相關的透析導管可能導致肺栓塞。 腔內閉塞是由血栓形成過程中纖維蛋白鞘的閉塞引起的。 此外,接受導管插入術的人患 CLABSI(中心導管相關血流感染)的風險增加。 透析導管錯位會導致血栓、感染和扭結。 因此,與導尿管相關的危害和問題將阻礙預測期內的市場增長。
COVID-19 的爆發擾亂了全球醫療保健系統。 這對泌尿科護理和泌尿科醫療保健專業人員具有重要意義。 由於世界各地 COVID-19 爆發的次數不斷增加,許多醫療機構不堪重負,重症患者不堪重負。 COVID-19毒株通常會導致患者出現嚴重的呼吸窘迫,有時會導致急性腎損傷和腎功能衰竭。 隨著全球感染 COVID-19 的人數增加,預計對透析的需求也會增加。
估計儀器行業將有良好的增長。 由於研究的改進和微創手術的使用增加,這個市場正在增長。 最常用的泌尿外科器械包括導尿管、膀胱鏡、內窺鏡、膀胱鉗、腎/腎結石鉗、光學取石鉗、尿道鉗、可視膀胱鏡器械、柔性膀胱鏡器械、Hohenfelner、前列腺切除器械、精密輸精管。
由於全球醫院和診所數量的增加,預計在預測期內,醫院和診所部門將以最快的複合年增長率增長。 推動這一市場增長的主要因素之一是對微創手術的需求不斷增加、手術技術的進步以及公眾對泌尿外科問題及其早期發現和治療的認識不斷提高。 政府計劃,包括對醫療設施建設的財政援助,預計也將在預測期內推動市場擴張。
預計在預測期內,歐洲將佔據最大的市場份額。 壓力性尿失禁和膀胱過度活動症的症狀在患者中很常見。 該地區三分之一的女性患有尿失禁,這被認為比花粉熱更常見。 隨著泌尿外科患者在醫院的流行,治療這些疾病的技術發展日趨活躍。 由於泌尿系統疾病的發病率和患病率上升以及人均醫療保健支出高,預計該地區的市場將顯著增長。
預計北美在預測期內的複合年增長率最高。 良性前列腺增生症 (BPH) 是泌尿外科服務最匱乏的領域之一,一些美國公司正在努力通過合作和收購來加強其在該領域的產品供應。 女孩隨著年齡的增長更容易感染,但男孩更可能在 1 歲之前感染。 此外,尿路感染 (UTI) 是成年女性最常見的門診感染,終生患病率為 50-60%。 在美國,UTI 佔每年就診的很大比例。 由於泌尿外科設備銷量的增加,這種疾病正在推動市場。 尿石症的社會和個人成本是巨大的。
2020 年 6 月,奧林巴斯公司在美國推出了 Soltive Superpulse 激光系統,供泌尿科醫生用於軟組織治療和碎石。
According to Stratistics MRC, the Global Urology Devices Market is accounted for $40.31 billion in 2022 and is expected to reach $57.51 billion by 2028 growing at a CAGR of 6.1% during the forecast period. Medical equipment called urology devices is used to identify different urologic illnesses. Several urologic problems, such as urinary tract infections (UTI), kidney illness, urethral cancer, urine incontinence, urolithiasis, and others, can be treated with the use of these cutting-edge procedures.
According to the European Association of Urology, up to 31% of sepsis cases begin as UTIs, accounting for 2.8 million to 9.8 million cases in the US and Europe and resulting in as many as 1.6 million fatalities.
Chronic renal failure that progresses to ESRD is brought on by uncontrolled diabetes and untreated high blood pressure. Additionally, kidney stone illness is becoming more commonplace around the globe. Western nations frequently experience kidney stone illness. In Western nations, the lifetime prevalence of kidney stone disease varies from 8% to 12% for males and 5% to 7% for women. The most frequent risk factor for kidney stone disease is obesity. In OECD nations, approximately one in six kids and more than one in two adults are overweight or obese. Therefore, it is anticipated that throughout the projected period.
Due to a number of adverse consequences, including infections, haemorrhage, urine retention, and bladder perforation, the market adoption of cystoscopes has plummeted. According to MMR, the number of UTI infections related to office cystoscopy increased by 10-20% in 2020. It is anticipated that these adverse effects would limit the usage of cystoscopes to some extent. Additionally, the market expansion is being hampered by the high cost of urology equipment. Numerous governments and organisations are teaching urology hospitals about the drawbacks associated with the use of these devices. These infections connected to urology devices are predicted to impede market expansion.
One of the main difficulties of BPH therapy is dealing with sexual issues. Ejaculation issues and ED have been connected to the routinely used TURP therapy for BPH. Therefore, those who are worried about maintaining their sexual function should choose UroLift. For lithotripsy in the treatment of kidney stones, thulium fibre lasers (TFLs) are being researched as a potential substitute for the holmium laser. In terms of lithotripsy, the TFL has a number of potential benefits over holmium lasers, including a four-fold lower ablation threshold, a nearly single-mode beam profile, and greater pulse rates.
Pneumoembolism from dialysis catheters linked to vein thrombosis is possible. An intraluminal occlusion results from the fibrin sheath becoming occluded during thrombosis. Furthermore, those who undergo catheterization are at a greater risk of CLABSI (Central Line-Associated Bloodstream Infections). Dialysis catheter misplacement can lead to clotting, infection, and kinking. Therefore, the market's growth potential would be hampered over the projection period by the dangers and issues related to urological catheters.
The COVID-19 outbreak has caused disruptions in global health systems. This has had a big influence on urological therapy and urology medical professionals. Numerous healthcare facilities are now overrun by very ill patients as a result of the rising COVID-19 instances throughout the world. The COVID-19 strain commonly causes patients to experience severe respiratory distress, which may occasionally result in acute renal impairment and kidney failure. The increased number of COVID-19-infected people throughout the world is anticipated to result in an increase in the requirement for dialysis procedures.
The instruments segment is estimated to have a lucrative growth. This market is expanding as a consequence of improving research and the growing usage of minimally invasive procedures. Some of the most frequently used urology devices include catheters, cystoscopy, endoscopes, bladder forceps, kidney and kidney stone forceps, optical stone forceps, urethra forceps, visual cystoscopic instruments, flexible cystoscopic instruments, hohenfellner, prostatectomy instruments, and precise spermatic instruments.
The hospitals and clinics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increasing number of hospitals and clinics around the world. One of the main reasons propelling the growth of this market is the increased demand for minimally invasive operations, technical advancements in surgical techniques, and growing public awareness of urological problems and their early identification and treatment. Government programmes including funding for the construction of healthcare facilities are also anticipated to fuel market expansion throughout the projected timeframe.
Europe is projected to hold the largest market share during the forecast period. Stress urine incontinence and symptoms of an overactive bladder are common among patients. One in three women in this area suffers from urinary incontinence, which is thought to be more frequent than hay fever. The prevalence of urology patients in hospitals has led to an increase in technical developments for treating these disorders. The regional market is anticipated to expand considerably due to the rising incidences and prevalence of urinary problems in the area as well as the high per capita healthcare spending.
North America is projected to have the highest CAGR over the forecast period. Benign prostatic hyperplasia (BPH) is one of the most underserved sectors in the urology sector, and several US-based companies are working to enhance their offerings in this space through collaborations or acquisitions. While girls are more prone to develop infections as they age, boys are more likely to do so before they are a year old. Additionally, the most common outpatient infections in adult women are urinary tract infections (UTIs), which have a lifetime prevalence of between 50 and 60 percent. UTIs account for a large percentage of yearly medical visits in the United States. As a result of increased urological equipment sales, this condition propels the market. The societal and personal costs of UTIs are enormous.
Some of the key players profiled in the Urology Devices Market include Medtronic Plc, Boston Scientific Corp., Olympus Corp., Urotech Devices, Richard Wolf GmbH, Stryker Corp., Siemens AG, Baxter International Inc., Cook Medical Incorporated, Karl Storz SE & Co. KG, Becton, Dickinson and Company, Endo Pharmaceuticals Inc, Cardinal Health and Intuitive Surgical.
In June 2020, Olympus Corporation introduced the Soltive SuperPulsed Laser System in the US as a device for urologists to use for soft tissue treatment and stone lithotripsy.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.